Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)

DB11044ApprovedWithdrawnVaccinesInactivated Influenza B Virus Vaccine

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2007

Resolves to

What you can answer from here — as of July 27, 2026

290Drug interactionsStructured to mechanism, not free text
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
13Marketed productsAcross 1 country and 5 labellers
Sign in

Which companies are running trials of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated), in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account